Company intelligence / Profile preview

Towa International

Kadoma, Osaka, Japantowainternational.com ↗

Ownership: Private
Employees: ~930
Development stage: Commercial

Overview

Towa International is a pharmaceutical company focused on generic and value-added medicines with over 380 marketed drugs and 3 pipeline drugs. They recently received approval for manufacturing and marketing three ingredients and eight generic drug products, including Zonisamide OD Tablets and Micafungin Sodium for intravenous infusion in February 2024.

Therapeutic areas: OncologyMetabolic DisordersEndocrinologyPulmonologyImmunologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculestabletscapsulesinjectablespatcheseye drops
Industry: Biotech

Drug pipeline

3 assets

penicillamine

Commercial

2 more assets in the full pipeline.

Request access →

Partnerships

TIS Inc. (joint venture for T Square Solutions)

Beyond the preview

Go deeper on Towa International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Towa International.

Explore the full profile